Read Research Alzheimer's More' title='Share this by email.' class='social email'>           

AMYPAD Diagnostic and Patient Management Study: Rationale and design

Reimbursement of amyloid-PET is lagging due to the lack of definitive evidence on its clinical utility and cost-effectiveness. The Amyloid Imaging to Prevent Alzheimer’s Disease–Diagnostic and Patient Management Study (AMYPAD-DPMS) is designed to fill this gap. Read & Research Alzheimer’s More

Leave a Reply